Cases 101 - 110 of 984
BLAIR v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06632
Plaintiff:
CINDY LOU BLAIR
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL, CO., LTD., AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
OLIVER v. MYLAN LABORATORIES LTD. et al
as 1:2022cv06532
Plaintiff:
PETER T. OLIVER
Defendant:
MYLAN LABORATORIES, LTD., MYLAN N.V., MYLAN PHARMACEUTICALS, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BAKER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06466
Plaintiff:
DERWIN BAKER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GREKSA v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06468
Plaintiff:
BRENDA GREKSA
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HARDWICK v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06397
Plaintiff:
DIANE HARDWICK
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ENANDER v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06383
Plaintiff:
MARK ENANDER
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
PITTMAN v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06395
Plaintiff:
MARCUS PITTMAN
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KRESESKI v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06374
Plaintiff:
PATRICIA KRESESKI and THE ESTATE OF JOSEPH KRESESKI, SR.
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
TSAKALAS v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06294
Plaintiff:
DEBORAH TSAKALAS
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
